Midterm endothelial function and remodeling of radial artery grafts anastomosed to the aorta  by Gaudino, Mario et al.
T he radial artery (RA) is gaining wide acceptance asa complementary arterial conduit for myocardial
revascularization.1 Although the early angiographic
patency of RA grafts has been reported to be satisfacto-
ry,2-6 concerns have been expressed on the routine use
Background: The purpose of this study was to elucidate the midterm
endothelium-dependent vasodilatory capacity of radial artery grafts anasto-
mosed to the aorta, as well as their morphometric evolution with the time. 
Methods: Five years after surgery we evaluated the response of aorta-anasto-
mosed radial artery grafts to the endovascular infusion of acetylcholine in 11
of the first 61 patients operated on at our institution, and we compared it to
the response with that of internal thoracic artery grafts. Moreover, the first
20 patients who had a perfect radial artery graft on angiography at 1 year
were restudied at 5 years and subjected to a comparative analysis of the
diameters of the radial artery graft and the grafted coronary arteries.
Results: At midterm angiography, dilation of the 2 types of grafts was simi-
lar in response to acetylcholine administration (radial artery, from 2.61 ±
0.39 to 2.90 ± 0.34 mm; internal thoracic artery, from 2.68 ± 0.21 to 2.93 ±
0.27 mm; P = .01 for both). The diameters of aorta-anastomosed radial artery
grafts and grafted coronary arteries increased between both 1 and 5 years
according to angiographic studies (radial artery grafts, from 2.08 ± 0.45 to
2.54 ± 0.53 mm; grafted coronary arteries, from 1.92 ± 0.47 to 2.18 ± 0.41
mm; P < .001 for both), but the increase was greater for the radial artery
grafts (P < .001).
Conclusions: Aorta-anastomosed radial artery grafts maintain an appreciable
capacity for endothelium-dependent vasodilatation 5 years after implanta-
tion and undergo a progressive increase in luminal diameter with time. These
observations contradict the presumed tendency for progressive fibrous inti-
mal hyperplasia to develop in radial artery grafts.  (J Thorac Cardiovasc Surg
2000;120:298-301)
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of this artery, mainly on the basis of its presumed hyper-
reactivity and the propensity for fibrous intimal hyper-
plasia to develop when the RA is anastomosed to the
ascending aorta.7-9
This study was conceived to elucidate the midterm
endothelium-dependent vasodilatory capacity of RA
grafts anastomosed to the ascending aorta (AARA), as
well as their morphometric evolution with the time.
Patients and methods
After approval by the Ethic Committee of the Catholic
University of Rome, a study on the use of the RA as a coro-
nary artery bypass conduit was prospectively started in
January 1993. The 3 main objectives of the study were to
establish (1) the midterm and long-term clinical and angio-
graphic results of RA grafts, (2) the long-term effect of RA
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expressed as absolute and percentage differences from base-
line values. AARA and ITA diameters at baseline and in
response to acetylcholine infusion, as well as AARA and
grafted coronary artery diameters at 1 and 5 years of follow-
up, were compared by 2-way analysis of variance for repeat-
ed measures, for F values less than 0.05. Pairwise compar-
isons were then performed by means of the Newman-Keuls t
test for paired data. Diameters of AARA and ITA grafts and
grafted coronary arteries were compared by means of the
Student t test for unpaired data.
Results
The 28 patients included in this report are part of the
first 61 patients with AARA grafts restudied for
midterm angiographic follow-up at our institution;
their detailed angiographic results have already been
published.12 On angiography, all had a perfectly patent
AARA graft at 1 year. When restudied at 5 years, all 28
patients were confirmed to have a perfect AARA graft
(perfect patency rate: 100%).
Acetylcholine challenge. Both AARA and ITA
grafts increased significantly in diameter after acetyl-
choline infusion (respectively, from 2.61 ± 0.39 to 2.90
± 0.34 mm and from 2.68 ± 0.21 to 2.93 ± 0.27 mm; P
= .01 for both). The capacity of endothelium-dependent
vasodilatation was not appreciably different between
the 2 conduits (P = .60).
Serial measurement of RA diameter. Diameters of
AARA grafts and grafted coronary arteries at 1 year
were of comparable size (2.08 ± 0.45 mm vs 1.92 ±
0.47 mm; P = .25). AARA graft diameters increased by
22% at 5 years’ follow-up (2.08 ± 0.45 mm vs 2.54 ±
0.53 mm; P < .001), whereas the grafted coronary
arteries increased in diameter by 13.3% (1.92 ± 0.47
mm vs 2.18 ± 0.41 mm; P < .001). Overall, the absolute
diameter gain was much greater in AARA grafts than
in the grafted coronary arteries (0.46 ± 0.38 mm vs
0.27 ± 0.36 mm; P < .001).
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removal on the forearm blood supply, and (3) the midterm
endothelial function of RA grafts and their morphometric
evolution with the time.
The first 2 issues have already been addressed in other pub-
lications.10-13 The present report was conceived to clarify the
third point (RA midterm endothelial function and morpho-
metric evolution), which assumes particular relevance in view
of the concern expressed by some authors on the possible
accelerated development of intimal hyperplasia when RA
grafts are directly anastomosed to the ascending aorta.2-4
Patient population. A total of 28 patients were chosen from
the first 61 patients in whom the RA was directly anastomosed
to the ascending aorta (AARA grafts)—the first 20 in whom the
AARA was perfectly patent angiographically at 1 year and in
whom both the AARA graft and the corresponding grafted
coronary arteries were measured at 1 and 5 years’ follow-up and
11 patients with a perfect AARA graft at early angiography who
gave their approval for the performance of an acetylcholine
challenge during the 5-year follow-up. Three of the patients
subjected to serial measurement of the AARA and the grafted
coronary arteries also agreed to have the acetylcholine chal-
lenge and thus were included in both groups. 
The mean preoperative characteristics of the patients are
shown in Table I. Among the patients subjected to serial mea-
surement of the AARA and the grafted coronary arteries, the
RA was anastomosed to an obtuse marginal branch in 15
patients, a posterior descending branch in 3, and a first diag-
onal branch in 2 patients. The RA was anastomosed to an
obtuse marginal branch in all patients subjected to the acetyl-
choline challenge, except for the 2 patients in whom it was
used to revascularize a posterior descending branch.
Pharmacologic protocol and angiographic measure-
ments. Angiographic follow-up studies were always per-
formed via a femoral approach; all the implanted grafts and
the native coronary arteries were selectively cannulated and
visualized. For serial measurement of the AARAs and graft-
ed coronary arteries, great care was taken to have similar pro-
jections chosen for the measurement at early and midterm
follow-up and to use the one that best visualized both the
graft and the recipient artery. AARA and internal thoracic
artery (ITA) grafts were measured about 10 mm proximal to
the distal anastomosis, and the grafted coronary arteries were
measured about 10 mm distally (Fig 1).
In patients subjected to the acetylcholine challenge, all
vasoactive medications were suspended 4 days before angiog-
raphy, and acetylcholine chloride (Miovisin, Farmigea, Italy)
was selectively injected into AARA and ITA grafts at a concen-
tration of 10–6 mol/L and a rate of 90 mL/h for 3 minutes.
Angiographic images were measured with the use of quanti-
tative computerized angiography (Medis, Amsterdam, The
Netherlands), as this system has a lower detection limit of 0.6
mm. Structures with a lesser value were considered to be 0.6
mm in diameter. All measurements were carried out separately
by 2 different observers blinded to each other’s assessments.
Major discordances were resolved after common re-evaluation.
Statistical analysis. Data are expressed as mean ± 1 SD.
Changes in the diameter of the AARAs and ITAs were
Table I. Preoperative characteristics of the patients
Patients subjected Patients subjected 
to acetylcholine to  serial 
challenge quantitative measurement
Male/female 8/3 16/4
Mean age 53.2 ± 4.8 56.1 ± 3.6
Risk factors
Diabetes 2 3
Smoking 6 13
Hyperlipemia 4 9
Hypertension 3 8
Unstable angina 1 2
Previous AMI 3 7
Mean ejection fraction 0.59 ± 0.19 0.63 ± 0.21
AMI, Acute myocardial infarction.
Discussion
The easy accessibility and optimal caliber and length
of the RA, coupled with an increasing interest in arter-
ial grafts, had led to the growing use of this conduit in
coronary surgery. Several groups have reported favor-
able angiographic and clinical results.2-6 However, the
RA is a purely muscular artery with a strong vasoreac-
tive response to a variety of external stimuli, and some
authors have expressed concern about the potential
clinical consequences of its spastic tendency.7,8
Our group has shown that the hyperspastic character-
istic of the RA tends to decline with time12; in fact, the
early vasoconstrictive reaction of this conduit after
endovascular infusion of serotonin is significantly
reduced at midterm follow-up and does not differ from
that of ITA grafts, despite the known histologic and
biologic differences between these 2 arteries.7,14 These
findings are in accordance with the observation that
continuation of Ca++ channel blocker therapy after the
first postoperative year did not influence the patients’
clinical status and RA angiographic results.12
Another issue of major concern with regard to RA
grafts is their presumed propensity for the development
of flow-limiting degrees of intimal hyperplasia, especial-
ly when anastomosed directly to the ascending aorta. It
has been speculated that the histologic and structural
characteristics of the RA can render this conduit particu-
larly prone to vessel wall ischemia and consequent inti-
mal proliferation, especially when exposed to the hemo-
dynamic stress due to the sharp increase in ∆P/∆T pre-
sent in the initial part of the ascending aorta.4,7,9 For this
reason some authors have advocated performing the
proximal anastomosis of RA grafts to a vascular region
with a lower ∆P/∆T, such as an ITA graft.2,4
This study is in contrast to what is thought to be a ten-
dency of AARA grafts to be affected by intimal hyper-
plasia. In this study in patients who underwent compara-
tive measurements of the AARA at early and midterm
follow-up, the diameter of the artery significantly
increased over time; five years after surgery, AARA
grafts maintained an appreciable endothelium-dependent
vasodilating capacity not inferior to that of the gold stan-
dard ITA, which strongly argues against the presence of
a hyperplastic regenerated endothelium.
Although in the absence of histologic data or
endovascular echographic imaging of the graft wall the
development of intimal disease cannot be definitely
excluded, it seems that a favorable morphofunctional
remodeling of the RA grafts with a progressive reduc-
tion of the hyperspastic characteristic and an increase
in luminal diameter occur with time, even when the
conduit is directly anastomosed to the ascending aorta.
On the other hand, when exposed to a major increase in
flow (such as after creation of an arteriovenous fistula
in patients with dialysis-dependent renal failure), in
situ RAs undergo progressive remodeling, character-
ized by a striking increase in internal diameter without
vessel wall hypertrophy and with unchanged intimal
and medial thickening. This response further demon-
strates the low propensity of this artery to the develop-
ment of flow-induced intimal hyperplasia.15
In addition, our study shows that in the years after the
operation the diameter of both the AARAs and the target
coronary arteries increased significantly. Although the
exact physiologic basis of this phenomenon remains
unclear, the parallel increase of the diameters of the 2
vessels suggests that hemorheologic conditions could
play a major role in these changes. In fact, after success-
ful surgical grafting there is an obvious increase in flow
velocity and shear stress in both the conduit and the graft-
ed artery, and shear stress is known to be a powerful stim-
ulus for the production of nitric oxide, whose dilating
effect on the vessel wall is widely known.16 Thus the
superior dilatation of the AARA graft could probably be
explained on the basis of its demonstrated high sensitivi-
ty to nitric oxide17 and of the superior degree of freedom
from atherosclerotic involvement and consequent superi-
or production of endogenous vasodilators when com-
pared with grafted coronary arteries. 
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Fig 1. Site of angiographic measurements of radial artery
grafts (RA, 1), grafted coronary arteries (GCA, 2), and inter-
nal thoracic artery grafts (ITA, 3).
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In conclusion, follow-up several years after surgery
shows that the RA undergoes favorable morphologic
and functional remodeling with a progressive increase
in diameter and reduction of the early hyperspastic
characteristic while maintaining an appreciable capaci-
ty of endothelium-dependent vasodilatation. These
observations and the good angiographic results further
support the use of the RA as a complementary arterial
conduit for surgical myocardial revascularization.
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